This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chen, K. Articles by Miyauchi, Y. Search for Related Content PubMed PubMed Citation Articles by Chen, K. Articles by Miyauchi, Y. Social Bookmarking                         What's this?

Insulin-like Growth Factor-I Prevents Gut Atrophy and Maintains Intestinal Integrity in Septic Rats

First Department of Surgery, Kumamoto University School of Medicine, Japan, Department of Pediatric Surgery, Osaka University, Medical School, Osaka, Japan

Toshitada Okuma, MD

First Department of Surgery, Kumamoto University School of Medicine, Japan

Kenji Okamura, MD

First Department of Surgery, Kumamoto University School of Medicine, Japan

Yoichi Tabira, MD

First Department of Surgery, Kumamoto University School of Medicine, Japan

Hirofumi Kaneko, MD

First Department of Surgery, Kumamoto University School of Medicine, Japan

Yoshimasa Miyauchi, MD

First Department of Surgery, Kumamoto University School of Medicine, Japan

Background: The effects of insulin-like growth factor-I (IGF-I) on gut metabolism, structure, and barrier function as well as its general anabolic effects were investigated in septic rats. Methods: Thirty-three male Wistar rats that underwent cecal ligation were randomly divided into one of the following two groups: (1) received only total parenteral nutrition(control group) or (2) received total parenteral nutrition with IGF-I (IGF group) at a dose of 4 mg/kg/d for 3 days. Results: During the 3-day period, the body weight of rats in the IGF group increased significantly over that of rats in the control group (17.1 ± 2.6 vs 5.8 ± 4.6 g, p < .01). The total and free IGF-I plasma concentrations were significantly higher in the IGF group than in the control group. The cumulative nitrogen balance was significantly more positive for the IGF group (423.9 ± 24.3 mg of nitrogen) than for the control group (290.8 ± 26.0 mg of nitrogen). The weights of thymus, spleen, and kidneys were significantly increased in the IGF group compared with weights in the control group. Treatment with IGF-I improved the gut mucosal weight in all regions of the gut examined, including duodenum, jejunum, ileum, and colon. Histologic and biochemical analyses of the jejunum showed greater villus height and crypt depth and higher mucosal DNA and protein content in the IGF group. The arterial concentration of endotoxin was not significantly different between the two groups, whereas its level in portal blood was significantly lower in the IGF group (23.2 ± 9.9 pg/mL) than in the control group (95.5 ± 37.9 pg/mL), an indication that IGF-I treatment decreased the amount of endotoxin that traversed the gut barrier. Conclusions: These results indicate that IGF-I can improve gut metabolism and reduce mucosal atrophy and that it may play a role in maintaining the gut barrier function in sepsis. (Journal of Parenteral and Enteral Nutrition 19:119-124, 1995)

Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 2, 119-124 (1995)
DOI: 10.1177/0148607195019002119


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Kai Chen, R. Nezu, M. Wasa, K. Sando, S. Kamata, Y. Takagi, and A. Okada Insulin-Like Growth Factor-1 Modulation of Intestinal Epithelial Cell Restitution JPEN J Parenter Enteral Nutr, September 1, 1999; 23(5_suppl): S89 - S92. [Abstract] [PDF]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]

				T. Inaba, H. Saito, R. Fukushima, Y. Hashiguchi, M.-T. Lin, T. Inoue, K. Fukatsu, T. Muto, T. Oka, A. Takenaka, et al. Insulin-Like Growth Factor 1 Has Beneficial Effects, Whereas Growth Hormone Has Limited Effects on Postoperative Protein Metabolism, Gut Integrity, and Splenic Weight in Rats With Chronic Mild Liver Injury JPEN J Parenter Enteral Nutr, March 1, 1997; 21(2): 55 - 62. [Abstract] [PDF]

				T. Inaba, H. Saito, R. Fukushima, Y. Hashiguchi, M.-T. Lin, T. Inoue, K. Fukatsu, T. Muto, A. Takenaka, S.-I. Takahashi, et al. Effects of Growth Hormone and Insulin-Like Growth Factor 1 (IGF-1) Treatments on the Nitrogen Metabolism and Hepatic IGF-1-Messenger RNA Expression in Postoperative Parenterally Fed Rats JPEN J Parenter Enteral Nutr, September 1, 1996; 20(5): 325 - 331. [Abstract] [PDF]